Picture of Arvinas logo

ARVN — Arvinas News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Arvinas Inc expected to post a loss of $1.41 a share - Earnings Preview

* Arvinas Inc  ARVN.OQ   ARVN.O  is expected to show a rise
in
quarterly revenue when it reports  results on May 3 (estimated)
for the period ending January 1 0001
    * The New Haven Connecticut-based  company is expected to
report a
7.2% increase in revenue to $34.838 million from $32.5 million a
year ago, according to the mean estimate from 11 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Arvinas Inc is for a
loss of
$1.41 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 18 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 6.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Arvinas Inc
is
$68.00​, above​ its last closing price of $31.77. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -1.20       -1.27      -2.53     Missed  -99.6
 Jan. 1 2023   -1.60       -1.58      -1.18     Beat    25.1
 Jun. 30 2023  -1.64       -1.65      -1.25     Beat    24.2​
 Mar. 31 2023  -1.56       -1.51      -1.54     Missed  -2.1
 ​​Dec.        -1.28       -1.16      -1.56     Missed  -34.4
 31 2022                                                
 Sep. 30 2022  -1.22       -1.13      -1.24     Missed  -9.8​
 Jun. 30 2022  -1.15       -1.04      -1.32     Missed  -27.5
 Mar. 31 2022  -0.90       -0.89      -1.20     Missed  -34.9
 This summary was machine generated May 1 at 12:42 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Arvinas

See all news